Published date: 31 May 2022
Last edited date: 8 June 2022
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Technical testing, analysis and consultancy services - 71600000
Technical analysis or consultancy services - 71621000
Research and development services and related consultancy services - 73000000
Research and development consultancy services - 73200000
Research consultancy services - 73210000
Development consultancy services - 73220000
Business and management consultancy services - 79410000
Business development consultancy services - 79411100
Production management consultancy services - 79415000
Evaluation consultancy services - 79419000
Environmental issues consultancy services - 90713000
Location of contract
BS1 3NU
Value of contract
£0 to £45,000
Procurement reference
20220531170214-45644
Published date
31 May 2022
Closing date
20 June 2022
Closing time
12pm
Contract start date
1 August 2022
Contract end date
31 December 2022
Contract type
Service contract
Procedure type
Other: Other
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) and North Bristol NHS Trust (NBT) are undertaking a competition to appoint a Service Provider who has the skills and expertise to undertake an options appraisal for the restructure of the UHBW and NBT Pharmacy Technical Services facilities. This is an ICS level review. NBT has one on site facility whilst the UHBW Pharmacy currently operates technical services in 4 locations within the Trust main precinct.
The option appraisal is being undertaken:
• To address a recognised unmet need in the preparation of aseptic products at UHBW and NBT and the wider NHS, as identified by the NHS Improvement Aseptic Services Review and the NHS England Releasing Time to Care agenda.
• To address expansion in new and more technically demanding therapies
• To address capacity and contingency issues locally, and to explore increasing capacity to support the wider NHS
• To identify how this enhanced service can add value across the system
• To identify opportunities for partnership working with neighbouring Trusts and commercial suppliers
• To identify system level support for NBT aseptic activities
• To enhance value added to the region through NBT and UHBW joint aseptic service, non-sterile manufacturing, repacking/over labelling.
The scope of project includes the following:
• A full market analysis of the current and future opportunities with the following considerations
Delivery of a UHBW and NBT solution
Delivery of an Integrated Care System (ICS) wide solution
Onsite or offsite solution
• An Options appraisal is to be carried out to look closely at possible solutions to future proof technical services in the region.
• This information will then inform SWOT analysis for each of the options chosen; with one option put forward the bidder will closely look at resources required to make it happen and benefits to patient care.
• The end product required is an Outline Business Case (which must include a Revenue Business Case) for preferred option supported by strong evidence. Strategic outline Business Case must also be written. This information will be used by UHBW and NBT to write a Full Business Case.
About the buyer
Contact name
BWPC Klaudia Palasti
Address
Princess Campbell Office (opposite Pathology)
Southmead Hospital
Bristol
BS10 5NB
ENG
Telephone
+44 1174142680
Share this notice
Closing: 20 June 2022, 12pm
All content is available under the
